Literature DB >> 10834048

Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

J G Fodor1, J J Frohlich, J J Genest, P R McPherson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10834048      PMCID： PMC1232457     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  26 in total

1.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

2.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

Authors:  J P Kane; M J Malloy; T A Ports; N R Phillips; J C Diehl; R J Havel
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

3.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

Authors:  L Cashin-Hemphill; W J Mack; J M Pogoda; M E Sanmarco; S P Azen; D H Blankenhorn
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

4.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

5.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Authors:  H Buchwald; R L Varco; J P Matts; J M Long; L L Fitch; G S Campbell; M B Pearce; A E Yellin; W A Edmiston; R D Smink
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

6.  Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

Authors:  W L Haskell; E L Alderman; J M Fair; D J Maron; S F Mackey; H R Superko; P T Williams; I M Johnstone; M A Champagne; R M Krauss
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

7.  Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

Authors:  G F Watts; B Lewis; J N Brunt; E S Lewis; D J Coltart; L D Smith; J I Mann; A V Swan
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

8.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

Authors:  W P Castelli; R J Garrison; P W Wilson; R D Abbott; S Kalousdian; W B Kannel
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

9.  Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.

Authors:  G Assmann; H Schulte
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

10.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321
View more
  44 in total

1.  Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol.

Authors:  J P Després; I Lemieux; G R Dagenais; B Cantin; B Lamarche
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

2.  Common problems in the management of hypertriglyceridemia.

Authors:  Michelle A Fung; Jiri J Frohlich
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

3.  Specificity of the commonly used enzymatic assay for plasma cholesterol determination.

Authors:  M H Moghadasian; J J Frohlich; C H Scudamore
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

Review 4.  The postprandial effects of dietary antioxidants in humans.

Authors:  Colin D Kay; Bruce J Holub
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 5.  Lipid lowering to delay the progression of coronary artery disease.

Authors:  Michael D Feher
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

6.  Practice tips. Preventing heart disease with ASA.

Authors:  Michelle Greiver
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

7.  Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.

Authors:  Jacques Genest; Jiri Frohlich; George Fodor; Ruth McPherson
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

8.  Are patients with hyperlipidemia undertreated? Study of patients admitted to hospital with coronary events.

Authors:  Alan H Lipson; Wendy M Fallis; Xiqui Wang; Yanqing Yi
Journal:  Can Fam Physician       Date:  2007-09       Impact factor: 3.275

9.  Statin use in Canadians: trends, determinants and persistence.

Authors:  C Ineke Neutel; Howard Morrison; Norm R C Campbell; Margaret de Groh
Journal:  Can J Public Health       Date:  2007 Sep-Oct

10.  Type 2 diabetes in family practice. Room for improvement.

Authors:  Stewart B Harris; Moira Stewart; Judith Belle Brown; Stephen Wetmore; Catherine Faulds; Susan Webster-Bogaert; Sheila Porter
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.